Agenda

Agenda

The growth of venture capital and venture capital-backed startups deserves the attention of healthcare leaders because advancements in medicine are no longer exclusively born from providers within the delivery system and increasingly from innovators outside of it. While venture capital-backed startups in digital health offer opportunities to affect the cost and quality of care, they often pose potential risks to patient care. An analytic framework for understanding the role of venture capital in medicine is still lacking.

​

Key topics:

​

The impact of startups in health care: the benefits and drawbacks

Establishing an evidence base that supported by a culture of change and innovation

Trends in M&A and VC investment in healthcare

Building successful business models centered on lowering spending in a revenue-maximizing system